Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
88 studies found for:    "Liposarcoma"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Conditions: Liposarcoma;   Surgically Unresectable Liposarcoma;   Metastatic Liposarcoma
Intervention: Drug: pazopanib
2 Completed
Has Results
Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Condition: Liposarcoma,Myxoid
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
3 Unknown  Brostallicin Clinical Trial for Myxoid Liposarcoma
Condition: Myxoid Liposarcoma
Intervention: Drug: Brostallicin
4 Recruiting Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
Condition: Myxoid Liposarcoma of Soft Tissue
Intervention: Radiation: dose reduction of preoperative radiotherapy in MLS
5 Recruiting Selinexor in Advanced Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Selinexor;   Drug: Placebo
6 Recruiting Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Condition: Liposarcoma
Interventions: Drug: HDM201;   Drug: LEE011
7 Recruiting A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Soft Tissue Sarcoma
Intervention: Drug: ribociclib
8 Active, not recruiting Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma
Condition: Liposarcoma
Intervention: Radiation: Radiotherapy
9 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
10 Suspended Ph II Cabazitaxel DD Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Cabazitaxel;   Drug: Prolonged infusional ifosfamide
11 Recruiting Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum
Conditions: Retroperitoneal Liposarcoma;   Retroperitoneal Leiomyosarcoma;   Chondrosarcoma
Intervention: Drug: Nilotinib-adriamycin
12 Active, not recruiting A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
13 Completed
Has Results
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Condition: Advanced Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
14 Active, not recruiting Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
Condition: Advanced and / or Metastatic Liposarcoma
Intervention: Drug: Pazopanib
15 Suspended Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients With Previously Treated, Unresectable Myxoid Liposarcoma
Condition: Liposarcoma
Interventions: Drug: efatutazone;   Drug: placebo
16 Recruiting Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Conditions: Conventional Chondrosarcoma;   Myxoid Liposarcoma;   Mesenchymal Chondrosarcoma;   Dedifferentiated Chondrosarcoma
Intervention: Drug: sirolimus and cyclophosphamide
17 Active, not recruiting PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
Conditions: Sarcoma;   Liposarcoma
Intervention: Drug: Palbociclib
18 Terminated
Has Results
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Conditions: Adult Liposarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: nelfinavir mesylate;   Procedure: biopsy;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Genetic: gene expression analysis;   Genetic: western blotting;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique
19 Recruiting SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo
20 Recruiting Study of Abemaciclib in Dedifferentiated Liposarcoma
Conditions: Sarcoma;   Dedifferentiated Liposarcoma
Intervention: Drug: Abemaciclib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years